In a new report, titled “Neuroprotective Products Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” Transparency Market Research (TMR) provides an in-depth assessment of the various factors supporting and restraining the market’s growth. The market is primarily gaining from the increasing incidence of neurodegenerative diseases such as Amyotrophic lateral sclerosis, Parkinson’s disease, Huntington’s disease, and Alzheimer’s disease.
The report provides a comprehensive study on the prevailing trends in the global neuroprotective products market, highlighting the drivers and restraints impacting its trajectory. To help the stakeholders gain a better perspective, the report also includes refined outlook for the market’s future. In addition, Porter’s five forces is conducted to gauge the bargaining position of suppliers and buyers. The analysis also presents insights into the degree of competition prevailing in the market. Besides these, the report compiles exhaustive information aimed at helping the leading market players take crucial business decisions.
As per TMR, the rising demand for advanced medication in the treatment of brain injury will be the key factor driving the global neuroprotective products market. Despite positive growth trends, stringent approval norms and high development costs could hamper the market’s growth to an extent.
Regionally, the global neuroprotective market can be segmented in Asia Pacific, Europe, North America, and Rest of the World. Currently, North America leads as the primary market due to the increasing number of neurodegenerative disorder cases it is witnessing over the last few years. As per the findings of the Alzheimer’s Association (AA), over 5.4 million people in the U.S. were diagnosed with Alzheimer’s disease in 2012. Furthermore, as per the Parkinson’s disease Foundation, every year around 60,000 Americans are diagnosed with the condition. With very little likelihood of the incidence to reduce anytime in the near future, the demand for neuroprotective products is likely to increase.
Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1976
Furthermore, Asia Pacific and Europe are expected to provide considerable opportunities to the market due to the rising incidence of neurodegenerative disorders witnessed in the region. The commercialization of personal medication will also create growth opportunities for the market in the aforementioned regions.
Besides the regional segmentation, by product the global neuroprotective products market can be classified into anti-inflammatory agents, anti-excitotoxic agents, neurotropic factors, metal ion chelators, ion channel modulations, mitochondrial dysfunction regulators, apoptosis inhibitors, gene therapy, and free radical trappers. Furthermore, based on medical condition, the market can be segmented into Multiple Sclerosis, Ocular Degeneration, Amyotrophic Lateral Sclerosis, Huntington\’s Disease, Alzheimer\’s Disease, Peripheral neuropathy, Parkinson\’s Disease, Brain Injury.
The report provides a detailed assessment of the various factors influencing the market’s growth across the segmentation. In addition the report profiles some of the leading players operating in the global neuroprotective products market. These include Genervon Biopharmaceuticals LLC, BHR Pharma LLC, Neuren Pharmaceuticals Limited, NeuroVive Pharmaceutical AB, Varinel Inc., and Allon Therapeutics Inc. Using SWOT analysis, the strengths and weaknesses of the companies profiled are studied in detail. The analysis is intended to help the market players identify the threats and opportunities that they might witness in the near future.